Agios Pharmaceuticals (AGIO) Divestments (2020 - 2021)
Agios Pharmaceuticals (AGIO) reported Divestments of $1.8 billion for Q1 2021, up 695080.69% on a YoY basis from N/an in Q1 2020, and up 395704.4% quarter-over-quarter from -$455000.0 in Q4 2020.
Agios Pharmaceuticals (AGIO) Divestments (2020 - 2021) Analysis & Trends
Agios Pharmaceuticals has reported Divestments for 2 years, with the latest figure at $1.8 billion in Q1 2021.
- For the quarter ending Q1 2021, Divestments rose 695080.69% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2022 stood at -$455000.0 (down 100.03% YoY), and the FY2024 full-year result was $200.0 million, changed N/A from the prior year.
- Divestments for Q1 2021 stood at $1.8 billion, up from -$455000.0 in the prior quarter.
- The five-year high for Divestments was $1.8 billion in Q1 2021, with the low at -$455000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.01 Bn | 2.01 Bn | 19.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1.80 Bn |
| Dec 31, 2020 | -455,000.00 |
| Jun 30, 2020 | -89,000.00 |
| Mar 31, 2020 | -259,000.00 |